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The aim of this study was to establish continuous therapeutic-dose ampicillin (CTDA)-
induced dysbiosis in a mouse model, mimicking typical adult exposure, with a view
to using this to assess its impact on gut microbiota, intestinal metabolites and host
immune responses. Mice were exposed to ampicillin for 14 days and antibiotic-induced
dysbiosis was evaluated by alteration of microbiota and gut permeability. The cecal index
was increased in the CTDA group, and the gut permeability indicated by fluorescent
dextran, endotoxin and D-Lactate in the serum was significantly increased after antibiotic
use. The tight-junction proteins ZO-1 and occludin in the colon were reduced to half
the control level in CTDA. We found that alpha-diversity was significantly decreased in
mice receiving CTDA, and microbial community structure was altered compared with
the control. Key taxa were identified as CTDA-specific, and the relative abundance
of Enterococcus and Klebsiella was particularly enriched while Lachnospiraceae,
Coprobacillus and Dorea were depleted after antibiotic treatment. In particular, a
significant increase in succinate and a reduction in butyrate was detected in CTDA mice,
and the triggering of NF-κB enhancement reflected that the host immune response
was influenced by ampicillin use. The observed perturbation of the microbiota was
accompanied by modulation of inflammatory state; this included increase in interferon-γ
and RegIIIγ, and a decrease in secretory IgA in the colon mucosa. This study allowed us
to identify the key taxa associated with an ampicillin-induced state of dysbiosis in mice
and to characterize the microbial communities via molecular profiling. Thus, this work
describes the bacterial ecology of antibiotic exposure model in combination with host
physiological characteristics at a detailed level of microbial taxa.
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INTRODUCTION
Since their discovery in the early twentieth century, antibiotics
have been used widely. In recent decades, antibiotic use has
accelerated and been accompanied by extensive public health
benefits. However, antibiotics are often used inappropriately; for
example, they may be prescribed for short periods to treat flu or
acute infections, or added to animal feed as growth promoters
(Vigre et al., 2008; Zhou et al., 2013). This overuse and misuse
of antibiotics is a worldwide problem, including in China, and
there are growing concerns that antibiotic exposure may lead
to short-term and/or long-term negative health consequences
(Hvistendahl, 2012; Wang et al., 2015).
A well-studied negative impact of antibiotic overuse is the
increased development and spread of antibiotic resistance in
bacteria. In contrast, the consequences of antibiotic usage on
the host’s gut microbial function has received less attention. Gut
microbiota play an important role in host metabolism and the
immune system (Tremaroli and Backhed, 2012; Caballero and
Pamer, 2015). Antibiotics are known to have a significant impact
on the composition and functionality of the gut microbiota in
humans and mice (Jernberg et al., 2007; Buffie et al., 2012),
and thus, perturbation of the microbiota through antibiotic
use could be detrimental to host health. Antibiotic-induced
alteration of the gut microbiota could also lead to metabolic
disorders, such as inflammatory bowel disease, diabetes and
obesity (Cho et al., 2012; Boursi et al., 2015; Becattini et al.,
2016).
Previous researches have focused on the effects of exposure to
combinations of antibiotics on subsequent disease development,
particularly asthma, allergies, diabetes and obesity. In our study,
we created a murine model of a single antibiotic treatment
to explore the consequences of short-term therapeutic-doses
of antibiotic on gut microbial ecology and function, and any
associated metabolic consequences. We chose ampicillin, a beta-
lactam, for this study because it is widely used and has a
broad spectrum of activity against various bacterial groups.
We used microbial biomarkers based on 16S rRNA gene
sequencing data for identification of the microbial groups
characteristic of antibiotic-induced dysbiosis and related diseases.
Our findings may have implications for antibiotic usage in human
clinical practice, routine prescriptions, and their application in
livestock.
MATERIALS AND METHODS
Animals and Treatments
Four-week-old male C57BL/6 mice (Slack Experimental Animal
Co., Ltd., Shanghai, China) were housed (in pairs) in the
Jiangnan University (Wuxi, China) animal facility for one week
to acclimatize. Mice were housed in pairs and randomized into
two groups (n = 8 per treatment group). Continuous therapeutic-
dose ampicillin (500 mg/kg, CTDA) was administrated via oral
gavage daily for 14 days (CTDA group) while 0.9% saline
solution was administrated for 14 days accordingly (Control
group). The dose of 500 mg/kg was calculated according to
the clinical adult dose and transferred to the experimental
mice dose (Nair and Jacob, 2016). All mice had ad libitum
access to water and chow (Slack Experimental Animal Co.,
Ltd., Shanghai, China), and the mice and their food intake
were weighed every 2 days. Fecal pellets were collected at
day 0, 7, and 14 throughout the experiment, the samples
collected from CTDA group at day 7 was named CTDA1 and
at day 14 was named CTDA2. At the end of the experiment
(day 14), all mice from two groups (Control and CTDA2
groups) were sacrificed and the colons, ceca and ilea excised
and frozen immediately in liquid nitrogen for further analysis.
The experiment was performed under the guidelines of the
Ethics Committee of Jiangnan University in China (JN No.
201501671) and every effort was made to minimize animal
suffering.
Microbial Community Analysis
Total genomic DNA was extracted from thawed fecal samples
using the FastDNA Spin Kit for Soil (MP Biomedical,
United States) and the 16S rRNA gene was amplified with a
forward (5′- CCT AYG GGR BGC ASC AG -3′) and reverse
(5′- GGA CTA CNN GGG TAT CTA AT -3′) barcoded primer
set, targeting the V3-V4 region, as previously described (Zhao
et al., 2013). Following purification and quantification of the
PCR amplicons, the libraries were prepared using the TruSeq
DNA LT Sample Preparation Kit (Illumina, United States)
and sequenced on the MiSeq platform (500 cycles paired-
end, Illumina). De-multiplexing 16S rRNA gene sequences,
quality control, and taxonomic assignment were performed
using the open source pipeline Quantitative Insights into
Microbial Ecology (QIIME) version 1.9.0. The ChimeraSlayer
was used to filter trimmed reads and RDP classifier was
used for bacterial taxonomy assignment with a confidence
value of 50% and trimmed reads clustered into operational
taxonomic units (OTUs) at 97% identity level, and calculated
diversity metrics in UniFrac analysis as described by Cox et al.
(2014).
Comparing Differential Abundance of Taxa
To identify significant differences in the relative abundance of
microbial taxa between Control and CTDA mice groups, the
linear discriminate analysis (LDA) effect size (LEfSe) algorithm
on the Galaxy browser was used (Segata et al., 2011). For LEfSe,
the non-parametric Kruskal–Wallis test was used first to identify
taxa that were significantly different in abundances followed by
LDA to determine the effect size. Taxa were considered to be
significantly different to each other if the P-value for the factorial
Kruskal–Wallis sum rank test was <0.05 and the logarithmic
LDA score was > 2.0.
Co-occurrence and Diversity of Taxa in Control and
CTDA Samples
To identify sets of OTUs that differed amongst the mice intestinal
microbiome samples from the Control and CTDA groups, we
visualized the co-occurrence network of the samples based on
genus level in Cytoscape (version 3.1.0) with an edge-weighted
spring-embedded layout. The input files were generated using the
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QIIME script make_otu_network.py on Control and CTDA fecal
samples.
Visualization of Community Structure
Using Non-metric Multidimensional
Scaling (NMDS) and Multivariate Analysis
Two dimensional visualizations of the whole community
structure were performed using NMDS with Bray–Curtis
distances at family or genus levels (Torondel et al., 2016).
Permutational multivariate analysis of variance was used
to determine if gut permeability variables had a significant
association with microbial community structure. We used
the implementation of permutational multivariate analysis of
variance (MANOVA) in the Adonis function of the vegan
package in R. In addition, to determine precisely how the
community structure differed between categorical variables,
we fitted Dirichlet-multinomial models to the community
compositions to each category separately (Holmes et al., 2012).
This allowed determination of differences in mean expected taxa
abundances and uncertainties in those predictions.
Identifying Metabolites by 1H NMR
Analysis
Thawed fecal samples (∼100 mg) were weighed and mixed with
saline phosphate buffer as described by Le Gall et al. (2011).
Samples were homogenized for 60 s, centrifuged (14,000 × g,
15 mins at 4◦C), the supernatants filtered through 0.2 µm
membrane, and 500 µL of each filtrate transferred to a 5 mm o.d.
NMR tube for metabolomic analysis.
1H NMR spectra were acquired on a Bruker Avance 600 MHz
NMR spectrometer (Bruker, Rheinstetten, Germany). Sample
temperature was controlled at 300 K. The noesypr1d pre-
saturation sequence was used to suppress the residual water signal
with low power selective irradiation at the water frequency during
the recycle delay (D1 = 2 s) and mixing time (D8 = 0.15 s). Spectra
were transformed with 1 Hz line broadening and zero filling,
and the baseline corrected using the TOPSPIN 2.0 software. The
“underground removal tool” of Bruker AMIX software v3.9 was
applied to all spectra to remove the broad irregular envelope
which extends from 0.7 to 4.5 ppm. The resulting spectra were
divided according to the horizontal axis into variable width
“buckets” using the AMIX graphical editor, and the intensities
within each bucket were summed.
Measurement of Cecum Indices
After the sacrifice, the wet weight of each mouse and its cecal
tissues were measured. Cecum index values were calculated using
wet weight of cecum tissue (g)/mouse weight (g).
Quantification of Intestinal Permeability
(Fluorescent Dextran, Diamine Oxidase,
Endotoxin, D-Lactate) in the Serum
Intestinal permeability was measured using 4000 Da fluorescent
dextran–FITC (DX-4000–FITC) (Sigma-Aldrich, United States)
as described by Cani et al. (2009). On the day 12, after fasting
for 6h, mice were administered with DX-4000–FITC (500 mg/kg
weight), and blood was collected from the vein at the tip of
the tail after 1 h. Serum was diluted (1:1 v/v) in PBS (pH
7.4) and after centrifugation (4,000 × g, 10 mins at 4◦C)
the concentration of DX-4000–FITC was measured using a
fluorescence spectrophotometer (VarioskanTM LUX multimode
microplate reader, Thermo Fisher Scientific, Finland) at an
excitation wavelength of 485 nm and an emission wavelength
of 535 nm. Serum sample was taken before sacrifice and the
concentrations of diamine oxidase (DAO), endotoxin (ET),
and D-lactate determined using Enzyme-Linked Immunosorbent
Assay (ELISA) kits (SenBeiJia Biological Technology Co., Ltd.,
Nanjing, China).
Measurement of Tight-Junction Proteins
in the Colon
To evaluate the integrity of the tight junctions between intestinal
epithelial cells, the colon tissues (100 mg) were sectioned and
were homogenized in 900 µL PBS using a Scientz-50 mortar-
grinder (Lanzhi, Ningbo, China), centrifuged at 13,000 × g
for 10 min, and the supernatants transferred into sterile tubes.
The expression of tight-junction proteins including zonula
occludens-1 (ZO-1) and occludin were measured using ELISA
kits (SenBeiJia Biological Technology Co., Ltd., Nanjing, China).
Immunofluorescence Staining of
Occludin for Tight Junction Morphology
Sections of ileal tissue were fixed in 4% paraformaldehyde and
permeabilized with 0.01% Triton-X prior to incubation with
primary occludin rabbit polyclonal antibody (Thermo Fisher
Scientific, United States) (1:200 dilution) for 2 h at 37◦C.
Sections were washed in PBS, and incubated with secondary
goat anti-rabbit IgG (1:100 in PBS) (Jackson Immuno Research,
United States) for 1 h. Sections were visualized on a fluorescence
microscope.
Measurement of Cytokine Levels in the
Colon
The supernatants of colon tissues from Control and CTDA2
groups were obtained using the method described previously
in Material and Methods (Expression of tight-junction proteins
in the colon). The levels of monocyte chemoattractant protein-
1 (MCP-1), interferon-γ (IFN-γ), secretory immunoglobulin
(sIgA), nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB), and regenerating islet derived protein III gamma
(RegIIIγ) were determined using specific ELISA kits following
the manufacturer’s instructions (Nanjing SenBeiJia Biological
Technology Co., Ltd., China).
Statistical Analysis
Results are presented as means ± SEM. Comparisons between
ampicillin-treated mice and Control mice were made using
unpaired two-tailed t-tests in GraphPad Prism version 7.00 for
windows. P< 0.05 was considered as a significant level. Statistical
differences amongst multiple treatment groups was determined
using one-way ANOVA (SPSS 11.0 software).
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Data Deposition
The datasets including raw reads and genome assemblies for this
study can be found in NCBI under Sequence Read Archive (SRA)
accession number of SRP135803.
RESULTS
Ampicillin Administration Alters Colonic
Microbial Communities
We examined 16S rRNA gene sequences to determine the effects
of ampicillin on the diversity of the colonic microbiota. At
both time points (day 7 and 14 of ampicillin use), the Shannon
diversity values in the CTDA groups were significantly lower than
that in the Control (P < 0.01) (Figure 1A). Quantitative PCR
showed that ampicillin significantly reduced the microbial total
numbers (p < 0.0001; Supplementary Figure S3).
After two weeks’ exposure, the fecal microbiota in the
CTDA2 group was distinct from the Control group in terms
of community structure (β-diversity). Bacterial communities in
the one-week samples (CTDA1 group) progressively diverged
from the Control group toward the CTDA2 profile (Figure 1B).
The Unifrac distances between the Control and CTDA groups
were significantly greater than intragroup distances (P < 0.01)
(Figure 1C). Overall, these results indicate that CTDA treatment
selected for a distinctive microbial community structure, and
the diversity and structure of the colonic microbiota among
treatment groups and the Control group were more distinct
following ampicillin administration over an increased period of
time.
CTDA Affects Microbiota Characteristics
Based on Taxa Abundances
Mice in both CTDA groups showed a complete loss of
Bacteroidetes and Verrucomicrobia, but an increase in the relative
proportions of Proteobacteria and Tenericutes at the phylum level
(Figure 2A). The taxonomic heatmap (Figure 2B), generated
using the Bray-Curtis dissimilarity index distance, combined
with the average clustering of statistically significant OTUs
between Control and CTDA samples, revealed that Klebsiella
and Anaeroplasma were significantly associated with ampicillin
use. The relative abundance of Enterococcus, Enterobacter
and Peptostreptococcaceae was higher in the two CTDA
groups compared with the Control group. Control samples
had a significantly higher abundance of Coprobacillus, Dorea,
Akkermansia, Eubacterium, Citrobacter, Ruminococcus and
Lachnospiraceae, which were almost completely lost in both the
CTDA1 and CTDA2 samples.
The LDA effect size (LEfSe) was applied specifically to identify
taxa that were differentially enriched at genus and family level
amongst treatments (Figures 2C,D). After modeling, particular
taxa including Klebsiella, Anaeroplasma, Enterococcus and
Enterobacter were over-represented in CTDA2 feces compared
with the Control. In contrast, Lachnospiraceae and Akkermansia
were enriched in the Control group rather than the CTDA2
group. Similarly, the relative abundance of Enterococcus and
Morganella increased, while Eubacterium, Blautia, Coprococcus,
Dorea and Akkermansia decreased significantly in the CTDA1
group compared with the Control group (Supplementary
Figures S1, S2). Furthermore, taxa co-occurrence network
analysis differentiated the microbiota between the Control and
CTDA2 groups; CTDA2 deviated substantially from the Control.
Although multiple constituent OTUs overlapped between the two
groups, specific genera could be used to distinguish CTDA2 from
the Control group (Figure 2E).
Focusing on specific microbial changes, CTDA treatment
affected multiple taxa, some of which were modulated
significantly after exposure. Levels of Lachnospiraceae and
Akkermansia were markedly diminished in the CTDA2 group
compared with the Control group (P < 0.01) (Figure 2F).
CTDA Affects Levels of Metabolic and
Inflammatory Biomarkers
Metabolomic analysis of fecal samples showed differences in
the profiles of specific metabolites between the Control and
the two CTDA groups. The intensity distributions of selected
metabolites indicated potentially negative alterations including a
consistent decrease in butyrate (P < 0.05) and 2-oxoisovalerate,
and an increase in succinate, tauro-bile acid, lactate and choline
in CTDA2 compared with the Control group (P < 0.01)
(Figure 3A).
Assessment of immunological makers indicated that the levels
of IFN-γ, NF-κB, MCP-1 and RegIIIγ were significantly increased
in the mice of CTDA2 group compared with the Control group
(Figure 3B). Production of sIgA was significantly reduced in the
CTDA2 group compared with the Control (P < 0.01).
Taken together, these results indicate the metabolic alteration
and increased intestinal immune responses in two-weeks CTDA
treatment of mice.
Establishment of the Continuous
Therapeutic-Dose Ampicillin Mouse
Model
During the ampicillin administration period, the weight of mice
in the CTDA group gradually decreased and was considerably
lower than the Control group (P < 0.05) on day 14, and the
food intake was significantly decreased (P < 0.05) in CTDA
group after day 7 (Figures 4A,B). The CTDA treated mice
exhibited significantly higher (P < 0.01) cecal index in cecum
and DX-4000-FITC in serum compared with the Control mice,
and increased levels of DAO, endotoxin and D-lactate were
observed in CTDA2 mice. The key markers of tight junction
integrity including colonic ZO-1 and occludin were reduced by
antibiotic treatment (Figure 4C). The examination of occludin
stained sections of the ileum confirmed that the levels of this
protein were reduced and became discontinuous in mice tissues
from CTDA2 group (Figure 4D), which was not observed in the
Control group.
A range of biomarkers were detected and measured in the
CTDA2 mice to establish a model that reflected the status of
gut dysbiosis and the impact on the intestinal barrier. The
major assessments selected included levels of the cecal index,
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FIGURE 1 | α- and β-diversity in Control, CTDA1, and CTDA2 fecal samples. (A) α-diversity as measured by the Shannon diversity index of microbiota in fecal
samples from different groups. The CTDA was administrated for 14 days and fecal samples were collected at day 7 (CTDA1 group) and day 14 (CTDA2 group), and
the 0.9% saline solution was administrated for 14 days and fecal samples were collected at day 14 (Control group), n = 8 per treatment group. The Shannon
diversity index for each microbial community was calculated at a depth of 5000 sequences per sample. Two-tailed student’s t-test was used to determine statistical
significance, ∗∗P < 0.01(B) Visualization of principal coordinates analysis (PCoA) of unweighted UniFrac distances to show differences in bacterial community
structure. The first principal component (PC1) and second principal component (PC2) explained 19.93 and 8.21% of the variance in the unweighted UniFrac metrics,
respectively. Each point represents the bacterial fecal microbiota in a single sample. (C) Pairwise unweighted Unifrac distance measurements of microbiota in fecal
samples from Control, CTDA1, and CTDA2 mice. Means ± SEM of the distances are shown. A two-tailed student’s t-test was used to determine statistical
significance, ∗∗P < 0.01. C = Control group, C1 = CTDA1 group, C2 = CTDA2 group.
gut permeability, and expression of tight-junction proteins,
that either increased or decreased significantly in the CTDA2
treatment group. Based on the combination of these major
biomarkers, we applied a non-metric multidimensional scaling
(NMDS) plot of the samples to establish a CTDA model
(Supplementary Table S1). In this model, the CTDA2 group
clearly clustered in an area totally separated from the Control
group (Figure 4E), implying that CTDA2 group was affected by
ampicillin administration and exhibited a profile different from
that in the Control group after 2 weeks exposure. In Figure 4F,
we plotted 8 families or genera with the largest difference in
abundance between the two groups. Klebsiella, Coprobacillus,
and Enterobacteriaceae were associated with ampicillin-induced
microbiota dysbiosis, while Lachnospiraceae were more likely
to be found in Control group. We also plotted the direction
of change in the three significant gut permeability variables
(Figure 4F). We observed that a host-microbiome correlation
exists and the tight-junction protein ZO-1 is negatively associated
with specific gut microbiota of antibiotic-induced dysbiosis,
while endotoxin and DAO are positively associated with such
dysbiosis status.
DISCUSSION
Numerous studies have reported dysbiosis of the gut microbiome
due to administration of a cocktail of antibiotics, however, very
few of these have looked at the impact of dysbiosis on the
gut barrier integrity or changes in the gut metabolome (Nobel
et al., 2015; Mahana et al., 2016). In this study, we established a
mouse model that provided CTDA to simulate typical exposure
in humans and explored how this single antibiotic modified the
gastrointestinal microbial community and its effect on the host
immune status and gut barrier function.
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FIGURE 2 | Characteristics of microbiota from Control and CTDA fecal samples. (A) Relative abundance of bacterial phyla in fecal samples from Control, CTDA1
and CTDA2 groups of mice. (B) Heatmap of differential taxa. Taxonomic Heatmap using Bray-Curtis Dissimilarity index distance, combined with Average
(unweighted pair-group method with arithmetic means) clustering for 41 of the most statistically significant OTUs between Control and CTDA samples. Yellow and
blue represent high and low abundance, respectively. (C) Identification of significant differences in bacterial taxa between CTDA2 and Control group. Cladogram
depicting differences and phylogenic location are shown. In each section, the diameter of the circle is proportional to the abundance of the taxon. Fecal microbial
communities from CTDA2 and Control mice were compared using LEfSe (green = taxon significantly enriched in Control; red = taxon significantly enriched in CTDA2;
yellow = non-significant). (D) Histogram of the LDA scores computed for features differentially abundant between the CTDA2 and Control groups. LEfSe scores
represent the degree of consistent difference in relative abundance between features in two groups of analyzed microbial communities. The clades of the histogram
(red indicating CTDA2 group, green indicating Control group) identifies statistical and biological differences between the communities. (E) Taxa co-occurrence
network. Cytoscape was used to visualize co-occurrence patterns for CTDA2 and Control mice at the genera level. In the network, samples were colored by
treatment group (Control samples = gray; CTDA2 samples = orange). Individual genera are represented by small black nodes. Lines connecting a sample to a genus,
colored by treatment group, indicate that the genus was observed in that specific sample. (F) Relative abundance of Enterococcus, Klebsiella, Enterobacter,
Akkermansia, and Lachnospiraceae in fecal samples from the CTDA and Control groups of mice. Boxes represent the interquartile range (IQR), median (horizontal
line within the box), range (whiskers) and outliers (crosses) (>1.5∗ IQR). A two-tailed student’s t-test was used to determine statistical significance, ∗∗P < 0.01.
Alteration of Specific Species Could
Trigger the Gut Disease
We observed that administration of ampicillin caused a boom
in Proteobacteria, and reduced the abundance of Firmicutes and
other phyla. This is consistent with other studies (Thompson
et al., 2015; Khan et al., 2016) which indicated a similar increase in
the abundance of Proteobacteria. This may explain the observed
weight loss in CTDA mice, which has also been observed
previously where an overabundance of Proteobacteria was
recorded (Zhang et al., 2009). An increased relative abundance
of Proteobacteria is also known to lead to a promotion of
the transfer of endotoxin and D-lactate across the intestinal
barrier, initiating inflammation (Cani et al., 2008). Consistent
with a prior study using cefixime (Shi et al., 2017), analysis
of β-diversity in the mice feces indicated that CTDA-exposed
microbial communities were distinct from the Control group.
The relative abundance of Lachnospiraceae decreased in both
the CTDA1 and CTDA2 groups compared with the Control
group. Patients with intestinal dysbiosis were also found to
have reduced abundance of Lachnospiraceae (Antharam et al.,
2013; Pham and Lawley, 2014). Several genera in this family
are fibre-degraders and produce short-chain fatty acids (SCFAs).
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FIGURE 3 | Metabolic and immunological outcomes of the CTDA mouse treatment. (A) Distribution of intensities for selected metabolites in the feces from Control
and CTDA groups of mice. Horizontal lines show mean and SEM. A two-tailed student’s t-test was used to determine statistical significance, ∗P < 0.05, ∗∗P < 0.01.
(B) Levels of inflammatory cytokines measured by ELISA in colonic tissues from Control and CTDA2 groups of mice. A two-tailed student’s t-test was used to
determine statistical significance, ∗∗P < 0.01. Error bars represent mean ± SEM (n = 8).
SCFAs enhance the intestinal barrier by regulating the assembly
of tight junctions; therefore, decreases in the abundance of
Lachnospiraceae has been implicated in the leaky gut process. Our
data in this study also found that ampicillin-induced dysbiosis
resulted in reduction of both levels of SCFAs and abundance of
Lachnospiraceae.
LEfSe analysis allowed the identification of key characteristics
of the microbiota in the CTDA model. As a tool, LEfSe is
used to predict which microbial taxa differ significantly between
test groups; it emphasizes statistical significance and biological
consistency, and identifies differentially abundant features that
are consistent with biologically meaningful categories (Segata
et al., 2011). Specific OTUs can differ between groups of
samples and several features of microbial communities have been
identified as potential biomarkers for many disease states (Lecuit
and Lortholary, 2005; Manichanh et al., 2006; Oakley et al., 2008).
In our study, the dominance of Klebsiella following ampicillin
exposure is noteworthy because, in humans, Klebsiella oxytoca
has been identified as the causative organism for antibiotic-
associated hemorrhagic colitis (Högenauer et al., 2006). Klebsiella
also has a key role in the initiation of pathological damage in
patients with Crohn’s disease (Rashid et al., 2013). Various studies
have suggested that commensal organisms, such as Enterococcus
and Klebsiella species, drive the pathogenesis of experimental
intestinal inflammation and human IBD (Sartor, 2006, 2008).
The high prevalence of Klebsiella, Enterococcus and Enterobacter
in the CTDA2 group, may be the consequence of antibiotic
perturbation of the microbiome. The observation that particular
species increased in abundance may be due to opportunistic
microbes that flourish when ecosystems are disrupted (Garrett
et al., 2010). Also, there are studies reported that ampicillin-
resistant Klebsiella and Enterococcus species exist (Klare et al.,
2005; Rashid et al., 2012), which could explain the significantly
increase in ampicillin group. The decrease in abundance of
Akkermansia in both CTDA groups is also a negative outcome
since A. muciniphila has been shown to reduce inflammation in
adipose tissues (Shin et al., 2014).
Succinate and Other SCFAs Indicated
the Dysbiosis Status
Notably, we observed that CTDA treatment leads to an increase
in levels of succinate in the intestinal lumen; this microbiota-
derived nutrient promotes pathogens such as Clostridium
difficile, and is associated with the development of colitis
and cell death (Ferreyra et al., 2014). Lipopolysaccharide
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FIGURE 4 | Establishing a CTDA mouse model based on key host biomarkers (A) = weight and (B) = food intake of mice. Day 4 was the first day of the adaptive
phase, ampicillin administration started on day 0, and the end point of ampicillin use was day 14. A two-tailed student’s t-test was used to determine statistical
significance, ∗P < 0.05. Error bars represent mean ± SEM (n = 8). (C) Main factors including cecal indices in cecum, biomarkers associated with the gut barrier
isolated from the serum and expression of tight-junction proteins in the colon of Control and CTDA2 mice. A two-tailed student’s t-test was used to determine
statistical significance, ∗∗P < 0.01. Error bars represent mean ± SEM (n = 8). (D) Images representing tight junction disruption (occludin) of the ileum in the Control
and CTDA2 groups of mice as determined by immunofluorescence (Representative images, n = 4/group). (E) Non-parametric monotonic relationship between the
dissimilarities in the samples of CTDA2 group (blue, right) and Control group (red, left) matrix. The spots site based on the abundance of microbial taxa,
measurement of cecal, colon, and serum samples which listed in C. (F) Non-metric multidimensional scaling plot of family and genus compositions for the Control
(red) and CTDA2 samples (blue) with the three featured variables (purple arrows) (DAO = diamine oxidase, ET = endotoxin, and ZO1 = tight-junction protein ZO-1)
plotted using the EnvFit function of package in R. The gray arrows give the top eight families or genera that most differ in expected proportion. f_Enterobacteriaceae,
g_K = f_Enterobacteriaceae, g_Klebsiella, f_Erysipelotrichaceae, g_Coproba = f__Erysipelotrichaceae, g__Coprobacillus, f_Enterococcaceae,
g_Enteroco = f_Enterococcaceae, and g_Enterococcus.
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(LPS) strongly increased the tricarboxylic acid (TCA) cycle
intermediate succinate. While succinate is also involved in
adenosine triphosphate generation in the host mitochondria, has
a signaling capacity; and is identified as a metabolite in innate
immune signaling which leads to enhanced IL-1β production via
HIF-1α during inflammation (Tannahill et al., 2013). Moreover,
the LPS endotoxin stimulation in macrophages is associated with
an increase in mitochondrial citrate carrier (CIC), possibly due
to activation of the NF-κB sites contained in the CIC promoter
(Infantino et al., 2011). The increased levels of endotoxin in
serum, and NF-κB in the colon, that we observed following
CTDA treatment also supported the fact that LPS induced the
activation of NF-κB pathway. We also observed elevated levels
of IFN-γ in CTDA mice, this was also demonstrated previously
which related to antigen-specific T cell activation when dendritic
cells (DCs) were primed simultaneously with succinate and
antigen (Rubic et al., 2008).
Acetate, propionate, and butyrate are the main SCFAs
produced during fermentation by the gut microbiota. In this
study, we found that fecal butyrate was reduced in both CTDA1
and CTDA2 groups while acetate and lactate increased in the
CTDA2 group compared with the Control. Butyrate is a major
energy source for intestinal epithelial cells, and is also believed
to have anti-inflammatory properties and the ability to enhance
epithelial antibacterial barrier defenses. Defects in butyrate
utilization by epithelial cells is thought to be characteristic
of antibiotic perturbation and IBD (Dethlefsen and Relman,
2011; Kostic et al., 2014). Increased levels of lactate have been
measured in feces from patients with ulcerative colitis (Hove
et al., 1994). The levels of tauro-bile acid were significantly higher
in both CTDA1 and CTDA2 groups compared with the Control,
while levels of bile acid only slightly increased in the CTDA2
group. Tauro-bile acids are a tauro-conjugated bile acid from a
subgroup in the bile acids and generally include taurocholic acid,
taurodeoxycholic acid, tauro-beta-muricholic acid, and tauro-
omega-muricholic acid, which are the main forms found in the
fecal samples of mice. Taurine may be present in fecal water as a
result of bacterial deconjugation of bile acids (Ridlon et al., 2006).
Enterococci are known to produce bile salt hydrolases (BSH)
that convert conjugated bile acids into free bile acids (Jiao et al.,
2017) and we speculate whether the increase in free bile acid is
a reflection of observed increase in abundance of Enterococcus.
Also, an increase in primary bile acids in the feces of diarrhea-
predominant IBS (IBS-D) patients has been detected and this
was correlated with dysbiosis of bacterial groups (Duboc et al.,
2012).
Microbe-Associated Ecological
Disturbances Led to a Leaky Gut
Increased gut permeability could trigger systemic inflammation
due to the movement of microbial elements across the epithelial
barrier, which is a known marker for intestinal health. Our data
suggest that the intestinal barrier was substantially compromised
in the ampicillin-induced dysbiosis model, indicated by
decreased ZO-1 and occludin levels in the colon. Meanwhile, the
increased levels of circulating 4 kDa FITC-dextran molecules
detected indicates a weakening of intestinal integrity following
ampicillin use. Indeed, translocation of pro-inflammatory
mediators, including endotoxin and D-lactate produced by
gram-negative enterobacteria, into the systemic circulation
(a phenomenon known as “leaky gut”) may play a role in
antibiotic-induced dysbiosis. Microbiota changes were also
accompanied by an increase in inflammatory activity in the
colon and serum. Microbe-associated molecular patterns
(MAMPS) can be sensed by intestinal epithelial cells, and induce
numerous effects including tissue repair and the production of
proteins such as RegIIIγ (a bactericidal C-type lectin) in the
intestinal epithelial. Microbiota-derived LPS maintains basal
level expression of RegIIIγ in intestinal epithelial cells; RegIIIγ is
not detected in germ-free mice and was impaired by short-term
antibiotic treatments evaluated in previous studies (Cash et al.,
2006; Brandl et al., 2008). Consistent with increasing levels of
circulating endotoxin, the expression of RegIIIγ is consequently
increased, which is linked to the proliferation of intestinal
macrophages (Yoshiok et al., 2009). The composition of CD4+
T cells within the intestinal mucosa, DC migration and IL-1β
production had been shown to be impaired in antibiotic-treated
mice (Ichinohe et al., 2011; Hooper et al., 2012). Our results
are also in agreement with the study of Yoshiok et al. (2009),
which used β-lactam antibiotics to enhance the development
of a systemic inflammatory response. This is achieved through
stimulation of endothelial cells with the consequence that
granulocytes are enhanced and quantities of MCP-1 are secreted
(van Langevelde et al., 1999).
By profiling the microbial 16S rRNA gene, we identified
key members of the microbiota that were impacted by either
antibiotic exposure or corresponded host physiological changes.
If humans have analogous bacterial species, their loss due to
antibiotic effects may have important consequences for host
health. Furthermore, humans tend to consume a more varied
diet and are exposed to a wider range of antibiotics than
experimental mice, which may introduce factors that influence
recovery from metabolic disruption. However, the development
of animal models provides insights into the potential impact of
antibiotics on microbiota and how this may relate to metabolic
and immunological changes, which may be mirrored in humans.
Based on this research, further studies are needed to evaluate the
interactions between specific metabolites and key members of the
gut microbiota, and to examine whether these effects are similar
in humans.
CONCLUSION
In conclusion, treatment with typical dose of ampicillin affects
the diversity and structure on the gut microbiota, and the
differentially abundant features were detected using LEfSe
algorithm. The NMDS ecological profiling characterized the
microbiota in the ampicillin-induced dysbiosis model, and
revealed the specific alterations of bacterial communities were
associated to the endotoxin level and expression of tight-
junction protein ZO-1. In addition, ampicillin-induced dysbiosis
affects the metabolome of mice, and significantly impacts cecal
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magnitude, gut permeability, and colonic immunity. Based on the
determination of gut microbiota composition, metabolites, and
immunological barrier, we have developed a model to explore
the impact of antibiotic on host factors, and this model can be
used to test the effect of intervention strategies aimed at restoring
antibiotic induced damage.
AUTHOR CONTRIBUTIONS
YS, QZ, and HZ designed the experiments. YS carried out the
experiments and wrote the manuscript. GLG analyzed the NMR
experimental results. YS and LK analyzed the sequencing data
and developed the analysis tools. JZ and AN assisted with the
Illumina sequencing. AN and WC revised the manuscript.
FUNDING
This work was supported by the National Natural Science
Foundation of China (Grant Nos. 31470161 and 31601452),
National Natural Science Foundation of Jiangsu Province
(BK20160175), BBSRC Newton Fund Joint Center Award, and
the BBSRC Institute Strategic Programme on Gut Health and
Food Safety (BB/J004529/1).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fmicb.
2018.01948/full#supplementary-material
REFERENCES
Antharam, V. C., Li, E. C., Ishmael, A., Sharma, A., Mai, V., Rand, K. H., et al.
(2013). Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium
difficile infection and nosocomial diarrhea. J. Clin. Microbiol. 51, 2884–2892.
doi: 10.1128/JCM.00845-13
Becattini, S., Taur, Y., and Pamer, E. G. (2016). Antibiotic-induced changes in the
intestinal microbiota and disease. Trends Mol. Med. 22, 458–478. doi: 10.1016/
j.molmed.2016.04.003
Boursi, B., Mamtani, R., Haynes, K., and Yang, Y. X. (2015). The effect of
past antibiotic exposure on diabetes risk. Eur. J. Endocrinol. 172, 639–648.
doi: 10.1530/Eje-14-1163
Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., et al. (2008).
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune
deficits. Nature 455, 804–807. doi: 10.1038/nature07250
Buffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., et al.
(2012). Profound alterations of intestinal microbiota following a single dose of
clindamycin results in sustained susceptibility to Clostridium difficile-induced
colitis. Infect. Immun. 80, 62–73. doi: 10.1128/Iai.05496-11
Caballero, S., and Pamer, E. G. (2015). Microbiota-mediated inflammation and
antimicrobial defense in the intestine. Annu. Rev. Immunol. 33, 227–256.
doi: 10.1146/annurev-immunol-032713-120238
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M.,
et al. (2008). Changes in gut microbiota control metabolic endotoxemia-
induced inflammation in high-fat diet-induced obesity and diabetes in mice.
Diabetes Metab. Res. Rev 57, 1470–1481. doi: 10.2337/db07-1403
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al.
(2009). Changes in gut microbiota control inflammation in obese mice through
a mechanism involving GLP-2-driven improvement of gut permeability. Gut
58, 1091–1103. doi: 10.1136/gut.2008.165886
Cash, H. L., Whitham, C. V., Behrendt, C. L., and Hooper, L. V. (2006). Symbiotic
bacteria direct expression of an intestinal bactericidal lectin. Science 313,
1126–1130. doi: 10.1126/science.1127119
Cho, I., Yamanishi, S., Cox, L., Methe, B. A., Zavadil, J., Li, K., et al. (2012).
Antibiotics in early life alter the murine colonic microbiome and adiposity.
Nature 488, 621–626. doi: 10.1038/nature11400
Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I.,
et al. (2014). Altering the intestinal microbiota during a critical developmental
window has lasting metabolic consequences. Cell 158, 705–721. doi: 10.1016/j.
cell.2014.05.052
Dethlefsen, L., and Relman, D. A. (2011). Incomplete recovery and individualized
responses of the human distal gut microbiota to repeated antibiotic
perturbation. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl. 1), 4554–4561. doi: 10.
1073/pnas.1000087107
Duboc, H., Rainteau, D., Rajca, S., Humbert, L., Farabos, D., Maubert, M., et al.
(2012). Increase in fecal primary bile acids and dysbiosis in patients with
diarrhea-predominant irritable bowel syndrome. Neurogastroent. Motil. 24,
513–520. doi: 10.1111/j.1365-2982.2012.01893.x
Ferreyra, J. A., Wu, K. J., Hryckowian, A. J., Bouley, D. M., Weimer, B. C., and
Sonnenburg, J. L. (2014). Gut microbiota-produced succinate promotes C.
difficile infection after antibiotic treatment or motility disturbance. Cell Host
Microbe 16, 770–777. doi: 10.1016/j.chom.2014.11.003
Garrett, W. S., Gallini, C. A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney,
M. L., et al. (2010). Enterobacteriaceae act in concert with the gut microbiota
to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8,
292–300. doi: 10.1016/j.chom.2010.08.004
Högenauer, C., Langner, C., Beubler, E., Lippe, I. T., Schicho, R., Gorkiewicz, G.,
et al. (2006). Klebsiella oxytoca as a causative organism of antibiotic-
associated hemorrhagic colitis. N. Engl. J. Med. 355, 2418–2426. doi: 10.1056/
NEJMoa054765
Holmes, I., Harris, K., and Quince, C. (2012). Dirichlet multinomial mixtures:
generative models for microbial metagenomics. PLoS One 7:e30126. doi: 10.
1371/journal.pone.0030126
Hooper, L. V., Littman, D. R., and Macpherson, A. J. (2012). Interactions between
the microbiota and the immune system. Science 336, 1268–1273. doi: 10.1126/
science.1223490
Hove, H., Nordgaard-Andersen, I., and Mortensen, P. B. (1994). Faecal DL-
lactate concentration in 100 gastrointestinal patients. Scand. J. Gastroenterol.
29, 255–259. doi: 10.3109/00365529409090473
Hvistendahl, M. (2012). China takes aim at rampant antibiotic resistance. Science
336, 795–795. doi: 10.1126/science.336.6083.795
Ichinohe, T., Pang, I. K., Kumamoto, Y., Peaper, D. R., Ho, J. H., Murray, T. S.,
et al. (2011). Microbiota regulates immune defense against respiratory tract
influenza A virus infection. Proc. Natl. Acad. Sci. U.S.A. 108, 5354–5359.
doi: 10.1073/pnas.1019378108
Infantino, V., Convertini, P., Cucci, L., Panaro, M. A., Di Noia, M. A., Calvello, R.,
et al. (2011). The mitochondrial citrate carrier: a new player in inflammation.
Biochem. J. 438, 433–436. doi: 10.1042/BJ20111275
Jernberg, C., Lofmark, S., Edlund, C., and Jansson, J. K. (2007). Long-term
ecological impacts of antibiotic administration on the human intestinal
microbiota. ISME J. 1, 56–66. doi: 10.1038/ismej.2007.3
Jiao, N., Baker, S. S., Nugent, C. A., Tsompana, M., Guan, L. Y., Wang, Y., et al.
(2017). High-fat diet increases Clostridium clusters XIVa in obese rodents.
FASEB J 31, S1012.
Khan, I., Azhar, E. I., Abbas, A. T., Kumosani, T., Barbour, E. K., Raoult, D., et al.
(2016). Metagenomic analysis of antibiotic-induced changes in gut microbiota
in a pregnant rat model. Front. Pharmacol. 7:104. doi: 10.3389/fphar.2016.
00104
Klare, I., Konstabel, C., Mueller-Bertling, S., Werner, G., Strommenger, B.,
Kettlitz, C., et al. (2005). Spread of ampicillin/vancomycin-resistant
Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying
the genes esp and hyl in German hospitals. Eur. J. Clin. Microbiol. 24, 815–825.
doi: 10.1007/s10096-005-0056-0
Kostic, A. D., Xavier, R. J., and Gevers, D. (2014). The microbiome in inflammatory
bowel disease: current status and the future ahead. Gastroenterology 146,
1489–1499. doi: 10.1053/j.gastro.2014.02.009
Frontiers in Microbiology | www.frontiersin.org 10 August 2018 | Volume 9 | Article 1948
fmicb-09-01948 August 17, 2018 Time: 18:40 # 11
Shi et al. Profiling of Ampicillin Exposure
Le Gall, G., Noor, S. O., Ridgway, K., Scovell, L., Jamieson, C., Johnson, I. T., et al.
(2011). Metabolomics of fecal extracts detects altered metabolic activity of gut
microbiota in ulcerative colitis and irritable bowel syndrome. J. Proteome Res.
10, 4208–4218. doi: 10.1021/pr2003598
Lecuit, M., and Lortholary, O. (2005). Immunoproliferative small intestinal disease
associated with Campylobacter jejuni. Med. Mal. Infect. 35(Suppl. 2), 56–58.
doi: 10.1016/S0399-077X(05)80278-1
Mahana, D., Trent, C. M., Kurtz, Z. D., Bokulich, N. A., Battaglia, T., Chung, J.,
et al. (2016). Antibiotic perturbation of the murine gut microbiome enhances
the adiposity, insulin resistance, and liver disease associated with high-fat diet.
Genome Med. 8:48. doi: 10.1186/s13073-016-0297-9
Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L.,
et al. (2006). Reduced diversity of faecal microbiota in Crohn’s disease revealed
by a metagenomic approach. Gut 55, 205–211. doi: 10.1136/gut.2005.073817
Nair, A. B., and Jacob, S. (2016). A simple practice guide for dose conversion
between animals and human. J. Basic. Clin. Pharm. 7, 27–31. doi: 10.4103/0976-
0105.177703
Nobel, Y. R., Cox, L. M., Kirigin, F. F., Bokulich, N. A., Yamanishi, S., Teitler, I., et al.
(2015). Metabolic and metagenomic outcomes from early-life pulsed antibiotic
treatment. Nat. Commun. 6:7486. doi: 10.1038/ncomms8486
Oakley, B. B., Fiedler, T. L., Marrazzo, J. M., and Fredricks, D. N. (2008). Diversity
of human vaginal bacterial communities and associations with clinically defined
bacterial vaginosis. Appl. Environ. Microbiol. 74, 4898–4909. doi: 10.1128/AEM.
02884-07
Pham, T. A., and Lawley, T. D. (2014). Emerging insights on intestinal dysbiosis
during bacterial infections. Curr. Opin. Microbiol. 17, 67–74. doi: 10.1016/j.mib.
2013.12.002
Rashid, M. U., Weintraub, A., and Nord, C. E. (2012). Effect of new antimicrobial
agents on the ecological balance of human microflora. Anaerobe 18, 249–253.
doi: 10.1016/j.anaerobe.2011.11.005
Rashid, T., Ebringer, A., and Wilson, C. (2013). The role of Klebsiella in Crohn’s
disease with a potential for the use of antimicrobial measures. Int. J. Rheumatol.
2013:610393. doi: 10.1155/2013/610393
Ridlon, J. M., Kang, D. J., and Hylemon, P. B. (2006). Bile salt biotransformations
by human intestinal bacteria. J. Lipid Res. 47, 241–259. doi: 10.1194/jlr.
R500013-JLR200
Rubic, T., Lametschwandtner, G., Jost, S., Hinteregger, S., Kund, J., Carballido-
Perrig, N., et al. (2008). Triggering the succinate receptor GPR91 on dendritic
cells enhances immunity. Nat. Immunol. 9, 1261–1269. doi: 10.1038/ni.1657
Sartor, R. B. (2006). Mechanisms of disease: pathogenesis of Crohn’s disease and
ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3, 390–407. doi: 10.
1038/ncpgasthep0528
Sartor, R. B. (2008). Microbial influences in inflammatory bowel diseases.
Gastroenterology 134, 577–594. doi: 10.1053/j.gastro.2007.11.059
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S.,
et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol.
12:R60. doi: 10.1186/gb-2011-12-6-r60
Shi, Y., Zhai, Q., Li, D., Mao, B., Liu, X., Zhao, J., et al. (2017). Restoration
of cefixime-induced gut microbiota changes by Lactobacillus cocktails and
fructooligosaccharides in a mouse model. Microbiol. Res. 200, 14–24. doi: 10.
1016/j.micres.2017.04.001
Shin, N. R., Lee, J. C., Lee, H. Y., Kim, M. S., Whon, T. W., Lee, M. S., et al.
(2014). An increase in the Akkermansia spp. population induced by metformin
treatment improves glucose homeostasis in diet-induced obese mice. Gut 63,
727–735. doi: 10.1136/gutjnl-2012-303839
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick,
A. F., Goel, G., et al. (2013). Succinate is a danger signal that induces IL-1β via
HIF-1α. Nature 496, 238–242. doi: 10.1038/nature11986
Thompson, J. A., Oliveira, R. A., Djukovic, A., Ubeda, C., and Xavier, K. B.
(2015). Manipulation of the quorum sensing signal AI-2 affects the antibiotic-
treated gut microbiota. Cell Rep. 10, 1861–1871. doi: 10.1016/j.celrep.2015.
02.049
Torondel, B., Ensink, J. H., Gundogdu, O., Ijaz, U. Z., Parkhill, J., Abdelahi, F., et al.
(2016). Assessment of the influence of intrinsic environmental and geographical
factors on the bacterial ecology of pit latrines. Microb. Biotechnol. 9, 209–223.
doi: 10.1111/1751-7915.12334
Tremaroli, V., and Backhed, F. (2012). Functional interactions between the
gut microbiota and host metabolism. Nature 489, 242–249. doi: 10.1038/
nature11552
van Langevelde, P., Ravensbergen, E., Grashoff, P., Beekhuizen, H., Groeneveld,
P. H. P., and van Dissel, J. T. (1999). Antibiotic-induced cell wall fragments
of Staphylococcus aureus increase endothelial chemokine secretion and
adhesiveness for granulocytes. Antimicrob. Agents Chemother. 43, 2984–2989.
Vigre, H., Larsen, P. B., Andreasen, M., Christensen, J., and Jorsal, S. E. (2008).
The effect of discontinued use of antimicrobial growth promoters on the
risk of therapeutic antibiotic treatment in Danish farrow-to-finish pig farms.
Epidemiol. Infect. 136, 92–107. doi: 10.1017/S095026880700814x
Wang, H. X., Wang, B., Zhao, Q., Zhao, Y. P., Fu, C. W., Feng, X., et al. (2015).
Antibiotic body burden of Chinese school children: a multisite biomonitoring-
based study. Environ. Sci. Technol. 49, 5070–5079. doi: 10.1021/es50
59428
Yoshiok, N., Taniguchi, Y., Yoshida, A., Nakata, K., Nishizwa, T., Inagawa, H., et al.
(2009). Intestinal macrophages involved in the homeostasis of the intestine have
the potential for responding to LPS. Anticancer. Res. 29, 4861–4865.
Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. (2009).
Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci.
U.S.A. 106, 2365–2370. doi: 10.1073/pnas.0812600106
Zhao, L., Wang, G., Siegel, P., He, C., Wang, H., Zhao, W., et al. (2013).
Quantitative genetic background of the host influences gut microbiomes in
chickens. Sci. Rep. 3:1163. doi: 10.1038/srep01163
Zhou, L. J., Ying, G. G., Liu, S., Zhang, R. Q., Lai, H. J., Chen, Z. F., et al. (2013).
Excretion masses and environmental occurrence of antibiotics in typical swine
and dairy cattle farms in China. Sci. Total Environ. 444, 183–195. doi: 10.1016/
j.scitotenv.2012.11.087
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Shi, Kellingray, Zhai, Le Gall, Narbad, Zhao, Zhang and Chen.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 11 August 2018 | Volume 9 | Article 1948
